series-a
Stage
2024
Founded
2
Investors
About
Develops a minimally invasive, ultrasound-based catheter system to treat pulmonary hypertension in patients with heart failure by reducing sympathetic input into the pulmonary vasculature.
Explore Gradient Denervation Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.